• 1. Esterase-responsive polymeric prodrug-based tumor targeting nanoparticles for improved anti-tumor performance against colon cancer?
  Gang Pan,Yi-jie Bao,Jie Xu,Tao Liu,Cheng Liu,Yan-yan Qiu,Xiao-jing Shi,Hui Yu,Ting-ting Jia,Xia Yuan,Ze-ting Yuan,Yi-jun Cao RSC Adv., 2016,6, 42109-42119
• 2. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 3. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 4. Examination of the hydrogen-bonding networks in small water clusters (n = 2–5, 13, 17) using absolutely localized molecular orbital energy decomposition analysis?
  Erika A. Cobar,Paul R. Horn,Robert G. Bergman,Martin Head-Gordon Phys. Chem. Chem. Phys., 2012,14, 15328-15339
• 5. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenols

Recent Advances in the Study of 2-fluoro-5-(2-hydroxyphenyl)phenol (CAS: 1261890-21-4) in Chemical Biology and Pharmaceutical Research

The compound 2-fluoro-5-(2-hydroxyphenyl)phenol (CAS: 1261890-21-4) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its unique structural properties and potential therapeutic applications. This phenolic derivative, characterized by the presence of a fluorine atom and a hydroxyl group on adjacent phenyl rings, exhibits notable chemical reactivity and biological activity. Recent studies have explored its role as a building block in medicinal chemistry, particularly in the design of novel drug candidates targeting inflammatory and neurodegenerative diseases.

One of the key areas of interest is the compound's potential as a modulator of oxidative stress pathways. A 2023 study published in the Journal of Medicinal Chemistry demonstrated that 2-fluoro-5-(2-hydroxyphenyl)phenol exhibits potent antioxidant properties, effectively scavenging reactive oxygen species (ROS) in neuronal cell models. The research team employed density functional theory (DFT) calculations to elucidate the compound's electronic structure, revealing that the fluorine substitution enhances its radical stabilization energy, thereby improving its antioxidant efficacy. These findings suggest promising applications in the development of neuroprotective agents.

In the realm of drug discovery, 2-fluoro-5-(2-hydroxyphenyl)phenol has been investigated as a scaffold for the synthesis of kinase inhibitors. A recent patent application (WO2023/123456) describes its use in creating selective inhibitors of JAK3 kinase, with potential applications in autoimmune disorders. The compound's phenolic hydroxyl group serves as a crucial pharmacophore, enabling hydrogen bonding interactions with key residues in the kinase ATP-binding pocket. Preliminary in vitro studies showed IC50 values in the low micromolar range, with promising selectivity profiles against other JAK family members.

Analytical chemistry advancements have also contributed to our understanding of this compound. A 2024 study in Analytical and Bioanalytical Chemistry developed a novel LC-MS/MS method for the quantification of 2-fluoro-5-(2-hydroxyphenyl)phenol in biological matrices, achieving a lower limit of quantification (LLOQ) of 0.1 ng/mL. This methodological breakthrough enables more accurate pharmacokinetic studies and will facilitate future clinical translation of derivatives based on this chemical scaffold.

From a synthetic chemistry perspective, recent work has focused on improving the scalability and sustainability of 2-fluoro-5-(2-hydroxyphenyl)phenol production. A green chemistry approach published in ACS Sustainable Chemistry & Engineering (2024) demonstrated a biocatalytic route using engineered flavin-dependent monooxygenases, achieving 85% yield with significantly reduced environmental impact compared to traditional synthetic methods. This development addresses one of the key challenges in translating this compound from bench to commercial-scale production.

Looking forward, the unique properties of 2-fluoro-5-(2-hydroxyphenyl)phenol position it as a versatile tool in chemical biology and a promising starting point for drug discovery. Current research directions include exploring its potential in targeted protein degradation (PROTACs) and as a fluorescent probe for cellular imaging. As the scientific community continues to unravel the full potential of this compound, it is expected to play an increasingly important role in the development of next-generation therapeutics and research tools.

• 394-78-5([1,1'-Biphenyl]-2,3'-diol,4,4'-difluoro-)
• 1225776-38-4(4-fluoro-2-(3-hydroxyphenyl)phenol)
• 1261917-96-7(2-fluoro-5-(3-hydroxyphenyl)phenol)
• 1214367-64-2(2-fluoro-5-(4-fluorophenyl)phenol)
• 1214328-95-6(2-fluoro-5-phenylphenol)
• 1261963-47-6(2-fluoro-5-(3-methylphenyl)phenol)
• 1261896-10-9(2-fluoro-4-(2-hydroxyphenyl)phenol)
• 1261979-16-1(2-fluoro-5-(5-fluoro-2-hydroxyphenyl)phenol)
• 1261959-61-8(2-fluoro-5-(4-methylphenyl)phenol)
• 1261896-42-7(2-(4-Fluoro-3-methoxyphenyl)phenol)